TegoScience Inc (191420) — Capital Reinvestment Ratio
Latest as of March 2024:
2.86x
TegoScience Inc (191420) has a Capital Reinvestment Ratio of 2.86x as of March 2024, meaning it reinvests 3% of its operating cash flow (₩48.13 Million) in capital expenditures (₩137.60 Million). See 191420 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
2.86x
Capex / Operating Cash Flow
Operating Cash Flow
₩48.13 Million
KRW
Capital Expenditures
₩137.60 Million
KRW
Data as of
Mar 2024
Most recent filing
TegoScience Inc Capital Reinvestment Ratio (2015–2022)
This chart tracks TegoScience Inc's Capital Reinvestment Ratio across 8 annual periods.
Annual Capital Reinvestment Ratio for TegoScience Inc (2015–2022)
Year-by-year Capital Reinvestment Ratio for TegoScience Inc from 2015 to 2022. For live market cap and broader valuation context, see market cap of TegoScience Inc.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.42x | ₩1.04 Billion | ₩435.55 Million | ▲ +1082.1% |
| 2021 | 0.04x | ₩457.25 Million | ₩16.19 Million | ▼ -30.5% |
| 2020 | 0.05x | ₩1.28 Billion | ₩65.18 Million | ▼ -96.5% |
| 2019 | 1.45x | ₩41.40 Million | ₩60.18 Million | ▲ +32.2% |
| 2018 | 1.10x | ₩833.88 Million | ₩916.72 Million | ▼ -69.5% |
| 2017 | 3.61x | ₩2.87 Billion | ₩10.34 Billion | ▲ +222.1% |
| 2016 | 1.12x | ₩2.36 Billion | ₩2.64 Billion | ▼ -33.7% |
| 2015 | 1.69x | ₩2.63 Billion | ₩4.45 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow